Table 2.
The basic characteristic of stroke survivors between the Egyptian versus Chinese female patients with or without sarcopenia.
| Variables | Stroke Survivors in Egyptian Patients | Stroke Survivors in Chinese Patients | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total, n (%) | Without Sarcopenic | With Sarcopenic | p-Value | Total | Without Sarcopenic | With Sarcopenic | p-Value | ||
| Gender | 200 | 195 | |||||||
| Males | 125(62.50) | 125(64.10) | |||||||
| Females | 75(37.50) | 49 | 26 | 70(35.90) | 60 | 10 | |||
| Age mean ± SD | 55.54 ± 13.1 | 56.5 ± 14.1 | 57.1 ± 15.6 | 0.857 c | 52.8 ± 15.15 | 53.4 ± 15.15 | 45 ± 13.7 | 0.143 c | |
| Modified Rankin median, IQR | 3(1–4) | 4(1–4) | 0.763 b | 4(3–4) | 4(3–4) | 4(3–4) | 0.467 b | ||
| Stroke type, n (%) | |||||||||
| Ischemic | 121(60.50) | 26(53.10) | 21(80.8%) | 0.018 a | 84(43.10) | 25(41.7%) |
8(80%) |
0.193 a | |
| Hemorrhagic | 79(39.50) | 23(46.9) | 5(19.2%) | 111(56.9) | 35(58.3%) | 2(20%) | |||
| Affected side, n (%) | |||||||||
| Right side Left side |
102(51) 98(49) |
20(40.8%) 29(59.2%) |
13(50%) 13(50%) |
0.446 a | 66(32.80) 129(66.20) |
16(26.6%) 44(73.3%) |
2(20%) 8(80%) |
0.438 a | |
| Smoking n (%) | |||||||||
| No | 110(55) | 49(100%) | 25(96.2%) | 0.167 a | 120(61.50) | 45(75%) | 7 (70%) | 0.738 a | |
| Yes | 90(45) | 0(0%) | 1(3.8%) | 75(38.50) | 15(25%) | 3(30%) | |||
| Drinking history, n (%) | |||||||||
| No | 200(100%) | 46(100%) |
29(100%) |
------ | 99(50.70) | 45(75%) | 4(60%) | 0.323 a | |
| Yes | 0(0.0) | 0(0.0) | 0(0%) | 96(49.20) | 15(25%) | 6(40%) | |||
| HTN, n (%) | |||||||||
| No | 29(14.50) | 9(18.4%) | 3(11.5%) |
0.443 a | 49(24.70) | 7(11.7%) |
1(10%) | 0.785 a | |
| Yes | 171(85.5%) | 40(81.6%) | 23(88.5%) | 146(73.7%) | 53(88.7%) | 9(90%) | |||
| DM, n (%) | |||||||||
| No | 118(59) | 25(51%) | 13(50%) | 0.933 a | 24(12.30) | 21(35%) | 3(30%) | 0.878 a | |
| Yes | 82(41) | 24(49%) | 13(50%) | 171(87.70) | 39(65%) | 7(70%) | |||
| IHD, n (%) | |||||||||
| No | 142(71) | 33(67.3%) | 16(61.5%) | 0.615 a | 165(84.60) | 55(91.7%) | 90(90%) | 0.862 a | |
| Yes | 58(29) | 16(32.7%) | 10(38.5%) | 30(15.40) | 5(8.6%) | 1(10%) | |||
| Performed conventional rehabilitation in the early phase, n (%) | |||||||||
| No | 116(58) | 30(61.2%) | 18(69.2%) | 0.492 a | 65(33.30) | 15(25%) | 8(80%) | 0.001 a | |
| Yes | 84(42) | 19(38.8%) | 8(30.8%) | 130(66.70) | 45(75%) | 2(20%) | |||
| Dyslipidemia | |||||||||
| NO | 140(70) | 35(71.4%) | 17(65.4%) | 0.589 a | 72(36.90) | 37(63.8%) |
9(75%) | 0.064 a | |
| Yes | 60(30) | 14(28.6%) | 10(34.6%) | 123(63.10) | 21(36.2%) | 3(25%) | |||
| Mini Nutritional Assessment-Short Form(MNA-SF) | |||||||||
| Malnutrition | 59(29.50) | 18(36.7%) | 13(46.2%) | 0.727 a | 65(33.30) | 23(38.3%) | 8(80%) | 0.027 a | |
| Risky | 59(29.50) | 15(30.6%) |
7(26.9%) | 45(23.07) | 14(23.3%) | 2(20%) | |||
| Normal | 82(41.0) | 15(32.7%) | 7(26.9%) | 85(43.50) | 23(38.3%) | 0 | |||
| FIM, median, IQR | |||||||||
| FIM motor | 48(45–72) | 60(41–71) | 42(42–71) | 0.683 b | 55(40–66) | 55(39–70) | 40(40–60) | 0.620 b | |
| FIM cognitive, | 31(28–33) | 31(29–32) | 30(27–34) | 0.884 b | 31(29–33) | 31(28–34) | 28(29–32) | 0.819 b | |
| FIM total | 81(72–105) | 60(71–103) | 78(69–104) | 0.781 b | 62(69–100) | 65(65–105) | 47(70–92) | 0.559 b | |
| Time from stroke onset per month, median, IQR | 57(34–43) | 38(33–42) | 35(34–44) | 0.492 b | 49(35–44) | 43(33–43) | 34(33–37) | 0.485 b | |
| Weight /KG | 71.62 ± 11.0 | 66.5 ± 10.5 | 68.12 ± 12.38 | 0.493 c | 69.9 ± 12.12 | 60.3 ± 9.1 | 59. 8 ± 4.8 | 0.886 c | |
| Height/M | 167.60 ± 8.1 | 159.1 ± 5.9 | 162.5 ± 7.2 | 0.036 c | 170.0 ± 7.26 | 161.7 ± 5.5 | 166.62 ± 3.7 | 0.010 c | |
| BMI (kg/m2) | 25.3 ± 4.20 | 25.4 ± 4.2 | 25.5 ± 5.7 | 0.883 c | 24.0 ± 3.04 | 22.9 ± 2.7 | 21.5 ± 1.9 | 0.123 c | |
| SMI (kg/m2) | 7.1 ± 1.50 | 6.5 ± 0.8 | 4.4 ± 0.56 | 0.000 c | 7.19 ± 1.24 | 6.8 ± 0.78 | 4.6 ± 0.57 | 0.000 c | |
| HG strength /kg | 23.32 ± 17.7 | 12.2 ± 9.1 | 12.2 ± 10.5 | 0.995 c | 29.2 ± 9.34 | 27.3 ± 8.3 | 14.8 ± 0.421 | 0.000 c | |
| Calf affected | 36.02 ± 4.7 | 37.6 ± 3.1 | 30.2 ± 6.5 | 0.000 c | 35.7 ± 3.40 | 34.6 ± 1.5 | 29.7 ± 2.34 | 0.000 c | |
| Calf unaffected | 36.3 ± 3.9 | 37.8 ± 3.1 | 31.4 ± 2.1 | 0.000 c | 35.56 ± 3.40 | 35.2 ± 2.01 | 29.1 ± 2.22 | 0.000 c | |
| CCI, median IQR | 4(3–5) | 4(2–5) | 6(3–6) | 0.069 b | 4(3–5) | 4(3–5) | 5(4–8) | 0.000 b | |
| SARC-F, median, IQR | 4(0–8) | 4(2–8) | 10(3–8) | 0.567 b | 4(2–8) | 4(3–8) | 6(7–8) | 0.000 b | |
| NIHSS, median, IQR | 5(3–9) | 5(4–10) | 10(4–10) | 0.567 b | 6(4–8) | 5(4–7) | 9(8–15) | 0.000 b | |
DM: diabetes mellitus, HTN: hypertension, IHD: ischemic heart disease, BMI: body mass index, SMI: skeletal muscle index, FIM: functional independence measure, NIHSS: National Institute of Health Stroke Scale, CCI: Carlson comorbidity index, a—Chi-square test, b—Manne–Whitney U test, c—t-test.